Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Dr Kein Yim is a Consultant Clinical Oncologist based in South Wales. He undertook his medical training in the prestigious institutions of Edinburgh, Cambridge, Birmingham, and London (at the Royal Marsden Hospital) and received his Certification of Board of Clinical Oncologists in 2007.
Dr Kein Yim’s specialist tumour sites are Colon, Lower GI, Upper GI, and Hepatobiliary. He sits on the Medical Advisory Board of Pancreatic Cancer UK and is also a Member of the European Pancreatic Cancer Academy, and the European School of Oncology. He is enthusiastically research active and holds a principal investigator role. His other areas of interest are:
Pancreas cancer
Liver cancer
Rectal cancer
Neuroendocrine tumours
Palliative cancer treatment
Symptom control
Immunotherapy
Radiotherapy
Bile duct cancer
Hepatocellular cancer
Small bowel cancer
Oesophageal cancer
Bone metastases
Chemotherapy
Targeted therapy
Clinical trials
Cholangiocarcinoma
Colon cancer
Duodenal cancer
Stomach cancer
Brain metastases
Biological therapy
Antibody therapy
Dr Kein Yim’s focus is to treat patients with fairness and compassion and provide them with the best appropriate treatment to achieve the best possible outcome. He is keen to introduce new treatments including cutting edge technology with Proton Beam Therapy, in order to provide the best possible care and treatment options for his patients.
Proton Beam Therapy
This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.
Dr Kein Yim does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Kein Yim does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Kein Yim does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.